NASDAQ:ETNB

89bio (ETNB) News Today

$15.44

0.00 (0.00%)

(As of 09/29/2023 ET)

Compare

Today's Range: $14.73
▼
$15.60
50-Day Range: $15.07
▼
$17.78
52-Week Range: $5.24
▼
$22.93

Volume: 2.46 million shs
Average Volume: 1.52 million shs
Market Capitalization: $1.17 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $37.44

Source

Source	Headline
	8,800 Shares in 89bio, Inc. (NASDAQ:ETNB) Acquired by Denali Advisors LLC marketbeat.com - September 29 at 6:43 AM
	89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Royal Bank of Canada americanbankingnews.com - September 24 at 3:08 AM
	RBC Capital Reiterates 89bio (ETNB) Outperform Recommendation nasdaq.com - September 23 at 8:01 AM
	The Latest Analyst Ratings for 89bio markets.businessinsider.com - September 22 at 4:59 PM
	RBC Capital Remains a Buy on 89bio (ETNB) markets.businessinsider.com - September 22 at 11:59 AM
	89bio Gets FDA Breakthrough Designation for Pegozafermin in NASH >ETNB marketwatch.com - September 21 at 12:24 PM
	H.C. Wainwright Sticks to Their Buy Rating for 89bio (ETNB) markets.businessinsider.com - September 21 at 12:24 PM
	89bio Announces U.S. FDA has Granted Breakthrough Therapy Designation for Pegozafermin in Nonalcoholic Steatohepatitis (NASH) finance.yahoo.com - September 21 at 12:24 PM
	89bio to Participate in the 2023 Cantor Global Healthcare Conference finance.yahoo.com - September 20 at 12:20 PM
	Great Point Partners LLC Acquires Shares of 250,000 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - September 12 at 10:12 AM
	89bio Insider Ups Holding By 41% During Year finance.yahoo.com - September 9 at 2:47 PM
	89bio to Participate in the H.C. Wainwright 25th Annual Global Investment Conference finance.yahoo.com - September 5 at 11:22 AM
	ExodusPoint Capital Management LP Makes New Investment in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - August 30 at 6:31 AM
	89bio earns ‘Buy’ rating in initial coverage on positive prospects for NASH therapeutic proactiveinvestors.com - August 28 at 4:42 PM
	E Fund Management Co. Ltd. Buys New Shares in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - August 23 at 8:55 AM
	89bio, Inc. (NASDAQ:ETNB) Forecasted to Post Q3 2023 Earnings of ($0.46) Per Share marketbeat.com - August 14 at 2:31 AM
	Cantor Fitzgerald Maintains 89bio (ETNB) Overweight Recommendation msn.com - August 11 at 10:47 PM
	RBC Capital Maintains 89bio (ETNB) Outperform Recommendation msn.com - August 11 at 12:28 AM
	HC Wainwright & Co. Reiterates 89bio (ETNB) Buy Recommendation msn.com - August 11 at 12:28 AM
	89bio, Inc.: A Big Bet On NASH seekingalpha.com - August 10 at 1:48 PM
	Federated Hermes Inc. Acquires New Stake in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - August 10 at 9:21 AM
	89bio, Inc.: 89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update finanznachrichten.de - August 10 at 8:16 AM
	89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - August 9 at 5:14 PM
	89bio, Inc. (NASDAQ:ETNB) Receives Average Rating of "Buy" from Analysts marketbeat.com - July 26 at 8:45 AM
	Virtu Financial LLC Acquires New Holdings in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - July 21 at 7:37 AM
	20,000 Shares in 89bio, Inc. (NASDAQ:ETNB) Bought by DekaBank Deutsche Girozentrale marketbeat.com - July 19 at 4:46 AM
	89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - July 12 at 5:19 PM
	Raymond James Financial Services Advisors Inc. Has $1.66 Million Holdings in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - July 12 at 4:15 AM
	Are Medical Stocks Lagging 89BIO (ETNB) This Year? finance.yahoo.com - July 7 at 11:36 AM
	Are Medical Stocks Lagging 89BIO (ETNB) This Year? finance.yahoo.com - July 7 at 11:36 AM
	89bio (ETNB) Price Target Increased by 6.60% to 38.19 msn.com - July 6 at 10:27 PM
	BTIG Maintains 89bio (ETNB) Buy Recommendation msn.com - July 3 at 1:34 PM
	BTIG Maintains Buy Rating for 89bio: Here's What You Need To Know markets.businessinsider.com - July 3 at 1:34 PM
	What 6 Analyst Ratings Have To Say About 89bio markets.businessinsider.com - July 3 at 8:34 AM
	89bio, Inc. (NASDAQ:ETNB) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - July 1 at 4:11 AM
	89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) in Nature Medicine finance.yahoo.com - June 24 at 10:14 AM
	Evercore ISI Group Initiates Coverage of 89bio (ETNB) with Outperform Recommendation msn.com - June 13 at 5:18 PM
	89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - June 7 at 6:32 PM
	SVB Securities Keeps Their Buy Rating on 89bio (ETNB) markets.businessinsider.com - June 7 at 8:31 AM
	89bio Announces Late-Breaker Oral Presentation of Data from the Phase 2 ENLIVEN Study of Pegozafermin at EASL International Liver Congress 2023 finance.yahoo.com - June 7 at 8:31 AM
	89bio, Inc. (NASDAQ:ETNB) Receives Consensus Rating of "Buy" from Analysts marketbeat.com - June 6 at 3:33 AM
	89bio (NASDAQ: ETNB) fool.com - June 4 at 8:05 PM
	89BIO (ETNB) Just Overtook the 20-Day Moving Average finance.yahoo.com - May 29 at 3:00 PM
	Raymond James Financial Services Advisors Inc. Sells 57,417 Shares of 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - May 28 at 4:47 AM
	89bio: Great Prospects After Excellent Phase 2 Data seekingalpha.com - May 28 at 4:18 AM
	89bio Initiates Phase 3 ENTRUST Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) finance.yahoo.com - May 23 at 9:41 AM
	89bio (ETNB) Investor Presentation - Slideshow seekingalpha.com - May 18 at 12:21 PM
	SG Americas Securities LLC Acquires New Shares in 89bio, Inc. (NASDAQ:ETNB) marketbeat.com - May 15 at 4:21 AM
	Institutional investors are 89bio, Inc.'s (NASDAQ:ETNB) biggest bettors and were rewarded after last week's US$90m market cap gain finance.yahoo.com - May 13 at 9:38 AM
	89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Buy" by Brokerages marketbeat.com - May 12 at 3:18 AM

Get 89bio News Delivered to You Automatically

ETNB Media Mentions By Week

ETNB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ETNB
News Sentiment
▼
0.43

0.68
▲
Average
Medical
News Sentiment

ETNB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ETNB Articles
This Week
▼
5

2
▲
ETNB Articles
Average Week

Get 89bio News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ETNB) was last updated on 9/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

89bio (ETNB) News Today

ETNB Media Mentions By Week

ETNB Media Sentiment

ETNB News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info